Jenna D. Goldberg

2.0k total citations · 1 hit paper
12 papers, 467 citations indexed

About

Jenna D. Goldberg is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Jenna D. Goldberg has authored 12 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Oncology and 2 papers in Surgery. Recurrent topics in Jenna D. Goldberg's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Jenna D. Goldberg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Jenna D. Goldberg collaborates with scholars based in United States, Netherlands and Singapore. Jenna D. Goldberg's co-authors include María‐Victoria Mateos, Jesús G. Berdeja, Paula Rodríguez‐Otero, Kodandaram Pillarisetti, Ajai Chari, Elham Askari, Suzette Girgis, Niels W.C.J. van de Donk, Xiang Yao and Jo Caers and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Cellular and Molecular Medicine.

In The Last Decade

Jenna D. Goldberg

12 papers receiving 461 citations

Hit Papers

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antib... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenna D. Goldberg United States 4 276 275 170 134 106 12 467
Larysa Sanchez United States 12 376 1.4× 335 1.2× 253 1.5× 118 0.9× 122 1.2× 65 606
Jenna D. Goldberg United States 16 513 1.9× 366 1.3× 178 1.0× 188 1.4× 131 1.2× 27 638
Raya Mawad United States 13 264 1.0× 214 0.8× 127 0.7× 88 0.7× 98 0.9× 38 459
Xing-Mei Cao China 11 179 0.6× 218 0.8× 191 1.1× 43 0.3× 188 1.8× 33 509
Zhao Yang United States 10 233 0.8× 199 0.7× 177 1.0× 73 0.5× 57 0.5× 21 408
Noa Biran United States 12 322 1.2× 226 0.8× 256 1.5× 38 0.3× 41 0.4× 89 427
Shebli Atrash United States 13 521 1.9× 454 1.7× 403 2.4× 73 0.5× 112 1.1× 119 752
Asaka Kondo Japan 6 208 0.8× 261 0.9× 113 0.7× 24 0.2× 242 2.3× 8 435
Morten Salomo Denmark 10 245 0.9× 170 0.6× 195 1.1× 38 0.3× 45 0.4× 29 344
Bernard A. Ruether Canada 14 364 1.3× 135 0.5× 130 0.8× 131 1.0× 172 1.6× 21 519

Countries citing papers authored by Jenna D. Goldberg

Since Specialization
Citations

This map shows the geographic impact of Jenna D. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna D. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna D. Goldberg more than expected).

Fields of papers citing papers by Jenna D. Goldberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenna D. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna D. Goldberg. The network helps show where Jenna D. Goldberg may publish in the future.

Co-authorship network of co-authors of Jenna D. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jenna D. Goldberg. A scholar is included among the top collaborators of Jenna D. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenna D. Goldberg. Jenna D. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chari, Ajai, Monique C. Minnema, Jesús G. Berdeja, et al.. (2022). Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. New England Journal of Medicine. 387(24). 2232–2244. 350 indexed citations breakdown →
2.
Jakubowski, Ann A., Molly Maloy, Patrick Hilden, et al.. (2017). T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 23(10). 1685–1694. 11 indexed citations
3.
Goldberg, Jenna D., Junting Zheng, Ravin Ratan, et al.. (2017). Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia & lymphoma. 58(8). 1859–1871. 44 indexed citations
4.
Ponce, Doris M., Sean M. Devlin, Marissa Lubin, et al.. (2014). High Disease-Free Survival and Enhanced Protection Against Relapse after Double-Unit Cord Blood Transplantation (DCB-T) When Compared to Unrelated Donor Transplantation (URD-T) in Patients with Acute Leukemia, MDS and CML. Biology of Blood and Marrow Transplantation. 20(2). S58–S59. 1 indexed citations
5.
Ponce, Doris M., Stephen Harnicar, Patrick Hilden, et al.. (2014). Intensified Mycophenolate Mofetil (MMF) Dosing Is Safe from the Standpoint of Engraftment and Reduces Severe Acute Graft-Versus-Host Disease (aGVHD) after Double-Unit Cord Blood Transplantation (DCBT): An Analysis of 173 Patients. Biology of Blood and Marrow Transplantation. 20(2). S279–S280. 1 indexed citations
6.
Vadhan‐Raj, Saroj, Jenna D. Goldberg, Miguel‐Angel Perales, Dietmar Berger, & Marcel R.M. van den Brink. (2013). Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. Journal of Cellular and Molecular Medicine. 17(11). 1371–1384. 52 indexed citations
8.
Ratan, Ravin, Patrick Hilden, Sean M. Devlin, et al.. (2013). The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS. Blood. 122(21). 2045–2045. 2 indexed citations
9.
Tamari, Roni, Parastoo B. Dahi, Sean M. Devlin, et al.. (2013). High Dose Therapy and Autologous Stem Cell Transplantation Results in Good Outcomes and Acceptable Toxicities in Elderly Patients with Non-Hodgkin's Lymphoma. Biology of Blood and Marrow Transplantation. 19(2). S133–S133. 1 indexed citations
11.
12.
Goldberg, Jenna D., Junting Zheng, Juliet N. Barker, et al.. (2009). Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.. Blood. 114(22). 2222–2222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026